Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 449,900
  • Shares Outstanding, K 1,363,334
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 36-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.68
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings 0.00 on 09/30/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.255 +27.45%
on 12/24/18
0.445 -26.97%
on 01/10/19
+0.035 (+12.07%)
since 12/18/18
3-Month
0.250 +30.00%
on 11/27/18
0.620 -47.58%
on 10/24/18
-0.265 (-44.92%)
since 10/18/18
52-Week
0.075 +333.33%
on 06/12/18
0.940 -65.43%
on 09/20/18
+0.205 (+170.83%)
since 05/29/18

Most Recent Stories

More News
Therapix Biosciences Provides Update Regarding FSD Acquisition

Therapix Biosciences Ltd. ("Therapix" or the "Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, is providing an update...

TRPX : 3.90 (-1.02%)
FSDDF : 0.2446 (+1.92%)
HUGE.CN : 0.325 (+3.17%)
FSD PHARMA Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer

FSD Pharma Inc. ("FSD Pharma" or "FSD") (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today the appointment of Rupert Haynes as Chief Executive Officer. Mr. Haynes is a highly accomplished...

FSDDF : 0.2446 (+1.92%)
GWPH : 137.29 (+2.07%)
HUGE.CN : 0.325 (+3.17%)
FSD Pharma adds David Urban to Board of Directors

FSD Pharma Inc. ("FSD Pharma" or the "Company") (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today the appointment of David Urban to the Company's Board of Directors.

FSDDF : 0.2446 (+1.92%)
HUGE.CN : 0.325 (+3.17%)
FSD Pharma Doubles Down on Cannabinoid Therapeutics with Therapix Acquisition -- CFN Media

via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FSD Pharma...

FSDDF : 0.2446 (+1.92%)
HUGE.CN : 0.325 (+3.17%)
FSD Pharma announces issuance of cannabis license under Excise Act

CSE: HUGEOTCQB: FSDDFFRA: 0K9

FSDDF : 0.2446 (+1.92%)
HUGE.CN : 0.325 (+3.17%)
InvestmentPitch Media Video Discusses FSD Pharma 's Pending Acquisition of Therapix Biosciences a Clinical-Stage Pharmaceutical Company Developing Unique Cannabinoid Technologies - Video Available on Investmentpitch.com

FSD Pharma Inc. (CSE: HUGE) (FSE:0K9) (OTCQB: FSDDF) has signed a binding letter of intent to acquire Therapix Biosciences Ltd. (NASDAQ:TRPX), a specialty clinical-stage pharmaceutical company developing...

TRPX : 3.90 (-1.02%)
FSDDF : 0.2446 (+1.92%)
HUGE.CN : 0.325 (+3.17%)
Therapix Biosciences Signs Binding LOI to be Acquired by FSD Pharma for $48 Million, to Create Medical Cannabis Industry Innovator

Therapix Biosciences Ltd. ("Therapix") (Nasdaq: TRPX) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today signing a binding letter...

TRPX : 3.90 (-1.02%)
FSDDF : 0.2446 (+1.92%)
THXBY : 4.0100 (unch)
HUGE.CN : 0.325 (+3.17%)
FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences, a Nasdaq Traded Pharmaceutical Company Focusing on the Development of Cannabinoid-Based Treatments to Create Medical Cannabis Industry Innovator

CSE: HUGEOTCQB: FSDDFFRA: 0K9

TRPX : 3.90 (-1.02%)
FSDDF : 0.2446 (+1.92%)
HUGE.CN : 0.325 (+3.17%)
CTV Toronto Highlights FSD Pharma's Cobourg Facility -- CFN Media

via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FSD Pharma...

ACBFF : 8.6900 (-12.80%)
FSDDF : 0.2446 (+1.92%)
HUGE : 0.2265 (+0.67%)
HUGE.CN : 0.325 (+3.17%)
FSD Pharma and SciCann Therapeutics to Attend the CannX International Medical Cannabis Convention in Tel Aviv Israel

CSE: HUGEOTCQB: FSDDFFRA: 0K9

FSDDF : 0.2446 (+1.92%)
HUGE.CN : 0.325 (+3.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 0.345
1st Resistance Point 0.335
Last Price 0.325
1st Support Level 0.315
2nd Support Level 0.305

See More

52-Week High 0.940
Fibonacci 61.8% 0.610
Fibonacci 50% 0.507
Fibonacci 38.2% 0.405
Last Price 0.325
52-Week Low 0.075

See More

Business Summary

FSD Pharma Inc is a publicly traded company. FSD through its wholly-owned subsidiary holds an Access to Cannabis for Medical Purposes Regulation license to cultivate cannabis.

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar